PLUS1
3.66
-0.09 (-2.4%)
-0.09 (-2.4%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eyenovia Inc | EYEN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.09 | -2.4% | 3.66 | 17:58:15 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 3.66 | 3.51 | 3.79 | 3.73 | 3.75 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.57 | 3.76 | 0.19 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,778 | 424,459 | $ 3.70 | $ 1,571,726 | 202,433 | 1.11 - 6.9048 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:04:11 | 25 | $ 3.62 | USD |
Eyenovia Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 90.89M | 24.83M | 18.01M | $ - | $ - | -1.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 43.73k | 9.30% |
Eyenovia News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/16/2020 | 17:05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 10/13/2020 | 12:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 10/13/2020 | 06:36 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10/05/2020 | 07:00 | Business Wire | Eyenovia to Present Clinical Study Updates at the American.. |
| 9/25/2020 | 13:42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 9/15/2020 | 16:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 9/15/2020 | 16:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EYEN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.59 | 4.0999 | 3.43 | 3.64 | 477,348 | 0.07 | 1.95% |
| 1 Month | 3.39 | 4.0999 | 2.90 | 3.41 | 231,472 | 0.27 | 7.96% |
| 3 Months | 3.78 | 6.9048 | 2.90 | 4.77 | 1,256,633 | -0.12 | -3.17% |
| 6 Months | 2.99 | 6.9048 | 2.5501 | 4.64 | 647,894 | 0.67 | 22.41% |
| 1 Year | 3.00 | 6.9048 | 1.11 | 4.52 | 362,397 | 0.66 | 22.0% |
| 3 Years | 10.00 | 10.74 | 1.11 | 4.51 | 187,482 | -6.34 | -63.4% |
| 5 Years | 10.00 | 10.74 | 1.11 | 4.51 | 187,482 | -6.34 | -63.4% |
Eyenovia Description
| Eyenovia Inc is a clinical-stage biopharmaceutical company operating in the US. It is engaged in developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver micro-therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. The pipeline products of the company are MicroProst for chronic angle closure glaucoma, MicroStat for pharmacologic mydriasis, MicroTears for dry eye and MicroPine for myopia. |
